1. Home
  2. KYMR vs RDNT Comparison

KYMR vs RDNT Comparison

Compare KYMR & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$69.51

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$71.57

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
RDNT
Founded
2015
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.7B
IPO Year
2020
1986

Fundamental Metrics

Financial Performance
Metric
KYMR
RDNT
Price
$69.51
$71.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
24
6
Target Price
$105.35
$85.00
AVG Volume (30 Days)
743.7K
742.3K
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,735,000.00
$1,969,599,000.00
Revenue This Year
$18.70
$11.82
Revenue Next Year
N/A
$11.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.09
52 Week Low
$19.45
$45.00
52 Week High
$103.00
$85.84

Technical Indicators

Market Signals
Indicator
KYMR
RDNT
Relative Strength Index (RSI) 39.39 40.42
Support Level $71.46 $70.54
Resistance Level $76.71 $81.21
Average True Range (ATR) 3.72 2.51
MACD -1.19 -0.11
Stochastic Oscillator 4.32 12.20

Price Performance

Historical Comparison
KYMR
RDNT

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Share on Social Networks: